#United States #Baltimore #Inflammatory Bowel Disease #intestinal ultrasound #Mercy Medical Center

Mercy Medical Center Elevates Patient Care with Intestinal Ultrasound

Mercy Medical Center in Baltimore, Maryland, has recently expanded its offerings in advanced digestive health services by introducing a cutting-edge technology: intestinal ultrasound (IUS). This innovation aims to improve the care of patients diagnosed with inflammatory bowel disease (IBD), making evaluations more efficient and less invasive.

Historically, monitoring IBD, including conditions like Crohn's disease and ulcerative colitis, has involved a range of procedures such as colonoscopies, blood tests, CT scans, and MRIs. While these methods have their efficacy, they often require patients to undergo bowel preparations, sedation, or face exposure to radiation. Moreover, results are not always immediately available, leading to potential delays in treatment decisions.

With the integration of intestinal ultrasound, Mercy Medical Center is offering a solution that significantly changes the game for IBD management. IUS is designed to be performed right at the bedside during a regular office visit. It provides physicians the ability to assess intestinal inflammation in real time—eliminating the need for radiation, anesthesia, or special preparation. This means quicker clinical decisions can be made and fosters a more meaningful dialogue between doctors and their patients.

The program spearheaded by Dr. Raymond K. Cross, Jr., M.D., a well-regarded gastroenterologist and Medical Director of The Center for Inflammatory Bowel and Colorectal Diseases at Mercy, underscores the center's commitment to innovative patient care. Dr. Cross emphasizes, “Intestinal ultrasound gives us the ability to evaluate inflammation at the time of an office visit. Because patients are awake and involved during the exam, they can see and understand what's happening in their intestines. That shared, real-time insight strengthens our ability to personalize treatment and monitor how therapies are working.”

Intestinal ultrasound technology is not novel on a global scale; it has been utilized in international settings for years as a standard practice in IBD management. Its proven ability to swiftly identify active inflammation, clarify whether symptoms stem from active disease, monitor the efficacy of medications and reduce the dependency on more invasive tests marks significant improvements in patient management strategies.

According to statistics from the Centers for Disease Control and Prevention, there is a rising trend in cases of inflammatory bowel disease in the U.S., with approximately 2.39 million to 3.1 million adults currently diagnosed. In response to this increasing prevalence, Mercy Medical Center is dedicated to providing advanced tools that ensure higher quality care, enhanced access, and improved patient comfort, all pivotal in supporting those dealing with complex digestive conditions.

Established in 1874, Mercy Medical Center stands as a Catholic healthcare facility under the sponsorship of the Sisters of Mercy. It also serves as a teaching hospital affiliated with the University of Maryland School of Medicine. Located in downtown Baltimore, it forms part of a network under Mercy Health Services, which includes Stella Maris, a significant long-term and geriatric care facility in Timonium, MD, along with a growing array of community health centers.

For those seeking further information, Mercy Medical Center welcomes inquiries through their official website at www.mdmercy.com or via their hotline at 1-800-M.D.-Mercy. This new technology is just one of the many ways Mercy Medical Center continues to innovate in patient care, positioning itself at the forefront of healthcare advancements and ensuring that the well-being of its patients remains the top priority.